LNN.NYSELindsay CORP

Form 4: Lindsay Corp Executive to Acquire Shares & Options

Sentiment:

Insider Transaction Report


Gustavo E. Oberto, President of Irrigation at Lindsay Corp, is scheduled to acquire 983 restricted stock units and 3,203 stock options on October 27, 2025.

Summary

  • Gustavo E. Oberto, President Irrigation, is scheduled to acquire 983 shares of common stock in the form of restricted stock units (RSUs) on October 27, 2025.
  • These RSUs were acquired at a price of $0 and will vest in three equal installments on November 1, 2026, November 1, 2027, and November 1, 2028.
  • Following this scheduled transaction, Oberto will directly beneficially own 6,907 shares of common stock, which includes shares from the 2021 Employee Stock Purchase Plan and other restricted stock units.
  • Oberto is also scheduled to acquire 3,203 derivative securities (options to purchase common stock) on October 27, 2025, with an exercise price of $114.41 and an expiration date of October 27, 2035.
  • These newly acquired options will vest in three equal annual installments beginning on November 1, 2026.
  • The filing also details several other existing stock options held by Oberto with various exercise prices and vesting schedules, including options that began vesting from November 1, 2020, through November 1, 2024.

Sentiment

Score: 7

Explanation: The scheduled acquisition of equity awards by a key executive is generally a positive signal, indicating continued alignment of interests and confidence in the company's future, although it is a routine compensation event reported under a 10b5-1 plan.

Positives

  • Scheduled acquisition of 983 restricted stock units (RSUs) at $0, indicating future equity ownership for the executive.
  • Scheduled grant of 3,203 stock options, aligning executive interests with shareholder value over the long term.

Future Outlook

This filing does not contain forward-looking statements or guidance beyond the vesting schedules of the equity awards, which extend through November 2028 for RSUs and October 2035 for options.

Industry Context

This filing, a Form 4, reports an individual insider transaction and does not provide broader industry context or trends.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of AttorneyGustavo E. Oberto granted a Power of Attorney to Eric Arneson, Brian Ketcham, and Ryan Loneman to execute and file Forms 3, 4, and 5 on his behalf, effective August 31, 2020. This is a standard practice for executives to ensure timely SEC compliance.2020-08-31Enhances efficiency and compliance for insider reporting requirements.

Related Party Transactions

  • The equity awards (restricted stock units and stock options) are part of the executive's compensation package, which is a standard related-party transaction between the company and its officer.

Stakeholder Impact

  • Shareholders: The equity grants align the executive's long-term interests with shareholder value creation, as the executive's wealth becomes tied to the company's stock performance.
  • Employees: The filing references Lindsay Corporation's 2021 Employee Stock Purchase Plan, indicating broader employee equity participation opportunities within the company.

Next Steps

  • Vesting of 983 restricted stock units in three equal installments on November 1, 2026, November 1, 2027, and November 1, 2028.
  • Vesting of 3,203 stock options in three equal annual installments beginning on November 1, 2026.
  • Continued vesting of other existing stock options as per their respective schedules.

Key Dates

DateDescription
2020-08-31Power of Attorney granted by Gustavo E. Oberto to Eric Arneson, Brian Ketcham, and Ryan Loneman for SEC filings.
2020-11-01Start of vesting for 2,326 stock options with an exercise price of $94.41.
2021-11-01Start of vesting for 171 stock options with an exercise price of $127.47 and 1,834 stock options with an exercise price of $110.42.
2022-11-01Start of vesting for 1,344 stock options with an exercise price of $145.93.
2023-11-01Start of vesting for 1,463 stock options with an exercise price of $156.16.
2024-11-01Start of vesting for 1,978 stock options with an exercise price of $120.54.
2025-10-27Scheduled transaction date for the acquisition of 983 restricted stock units and 3,203 stock options.
2025-10-29Date Form 4 was signed by the attorney-in-fact, reporting the scheduled transaction.
2025-11-01Start of vesting for 2,666 stock options with an exercise price of $121.16.
2026-11-01First installment vesting date for 983 restricted stock units and 3,203 stock options.
2027-11-01Second installment vesting date for 983 restricted stock units.
2028-11-01Third installment vesting date for 983 restricted stock units.
2029-10-31Expiration date for 2,326 stock options with an exercise price of $94.41.
2030-10-26Expiration date for 1,834 stock options with an exercise price of $110.42.
2031-01-04Expiration date for 171 stock options with an exercise price of $127.47.
2031-10-25Expiration date for 1,344 stock options with an exercise price of $145.93.
2032-10-24Expiration date for 1,463 stock options with an exercise price of $156.16.
2033-10-23Expiration date for 1,978 stock options with an exercise price of $120.54.
2034-10-28Expiration date for 2,666 stock options with an exercise price of $121.16.
2035-10-27Expiration date for 3,203 stock options with an exercise price of $114.41.

Recommendation

hold

This Form 4 reports a routine, scheduled grant of equity compensation to a key executive under a 10b5-1 plan. While it signals continued alignment of interests, it does not provide new fundamental information that would typically warrant a change in investment recommendation. Investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

Lindsay Corp, LNN, Gustavo E Oberto, Insider Transaction, Form 4, Stock Options, Restricted Stock Units, Executive Compensation, Equity Grant

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.